Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis

Clinical and Experimental Allergy

Volumn 31, Issue 12, 2001, Pages 1932-1938

  Noh, G ^a,c   Lozano, F ^b  

^a Sungkyunkwan University   (South Korea)

^b HOSPITAL CLÍNIC   (Spain)

^c NONE   (South Korea)

Author keywords

Atopic dermatitis; Eosinophil; IgE; IVIG; Soluble CD5

Indexed keywords

CD5 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; PLACEBO;

ABORTION; ANTIBODY BLOOD LEVEL; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EOSINOPHIL; EVALUATION; HUMAN; LEUKOCYTE COUNT; PRIORITY JOURNAL; RECURRENT DISEASE;

ANTIGENS, CD5; CYTOKINES; DERMATITIS, ATOPIC; EOSINOPHILS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULINS, INTRAVENOUS; KOREA; LEUKOCYTE COUNT; LEUKOCYTES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SOLUBILITY; TIME FACTORS;

EID: 0035660153     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01124.x     Document Type: Article

References (28)

1. High dose gammaglobulin treatment for atopic dermatitis
2. Intravenous immune globulin: An alternative therapy in steroid-dependent allergic diseases
3. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome
4. Intravenous immune globulin (IVIG) therapy in streroid-resistant atopic dermatitis
5. Acute infections in atopic dermatitis. A clue for a pathogenic role of a Th1/Th2 imbalance
6. IL-4 and interferon-gamma production in children with atopic disease
7. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis
8. Heterogeneity of atopy demonstrated by differences in cytokine release by peripheral blood T cells
9. Differences in IL-4 release by PBMC are related with heterogeneity of atopy
10. Blood eosinophil and serum IgE as predictors for prognosis of interferon-γ therapy in atopic dermatitis
11. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man
12. Identification of a p69, 71 complex expressed on human T cells sharing determinants with B-type chronic lymphocytic leukemia cells
13. Circulating soluble CD5 in atopic dermatitis
14. High-dose intravenous gamma globulin for Kawasaki disease
15. High-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood
16. Diagnostic features of atomic dermatitis
17. Scoring atopic dermatitis: The simpler the better?
18. Antibodies to the CD5 molecules in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)
19. Expression and regulation of CD5 on in vitro activated human B-cells
20. Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with staphylococcal superantigen
21. Atopic dermatitis. Correlation of peripheral blood T cell activation eosinophilia serum factors with clinical severity
22. The immunologic effects of IVIG in Kawasaki disease
23. Inhibition of IFN-gamma production by intravenous immunoglobulins during mixed lymphocyte reaction: Consequences for proliferation and TNF-gamma production
24. In vivo modulation of cytokine synthesis by intravenous immunoglobulin
25. Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo
26. A role for Th1 and Th2 cells in the immunopathogenesis for atopic dermatitis
27. Interleukin-10 is a predominant cytokine in atopic dermatitis
28. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease